BCM
MRTX

BCK Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

BCK Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,000
Closed -$940K – 107
2023
Q4 		$940K Buy
+16,000
New +$940K 0.92% 32